Bordeaux, Boston, 13 October 2015 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that the 10,000th JAZZ Band has been implanted. The consistent quarterly growth of Implanet’s Spine segment